Public Company News
Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment
NANJING, China, Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through its innovative products. The study, which focuses on how mutant IDH1 inhibition activates tumor ...
2024-09-16 19:00
3042
Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024
* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an overall response rate (ORR) of 21.1% and a disease control rate (DCR) of 89.5%. * Data from the...
2024-09-16 18:00
3403
China Automotive Systems Announces Annual Meeting on September 24, 2024
CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held onTuesday, September 24, 2024 at 9:00 AM local time, or 9:00 PM EDT onMonday, September 23, 2024 WUHAN, China, Sept. 16, 2024 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS)...
2024-09-16 18:00
5648
Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
HONG KONG, Sept. 16, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L) treatment for triple-negative breast cancer (TNBC). The prelimina...
2024-09-16 15:35
5989
Risen Energy Champions Environmental Stewardship for a Greener Future
NINGBO, China, Sept. 15, 2024 /PRNewswire/ -- On September 20, World Cleanup Day 2024 kicks off during the Clean Up the World Weekend (CUW Weekend), themed "make room for life." Since joining the UN Global Compact (UNGC) in 2021, Risen Energy, a leader in global photovoltaic (PV) innovation, has ...
2024-09-16 10:00
3359
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024
Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG, Sept. 15, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso released the Phase 2 clinical results of its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with or...
2024-09-15 15:10
4471
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by the U...
2024-09-14 19:43
5328
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immuno...
2024-09-14 16:06
5215
XCMG Unveils Major Lineup for MinExpo 2024, Showcasing Advanced Mining Solutions
LAS VEGAS, Sept. 13, 2024 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE: 000425) is set to present its largest-ever collection of mining equipment at MinExpo 2024, taking place fromSeptember 24-26 in Las Vegas. Visitors can find XCMG at booth#329 in the North Hall, where the company will feature a ...
2024-09-14 11:19
4837
Planet Image International Limited Reports the First Half of Fiscal Year 2024 Unaudited Financial Results
XINYU, China, Sept. 13, 2024 /PRNewswire/ -- Planet Image International Limited ("Planet Image," the "Company," "we," "our," or "us") (Nasdaq: YIBO), an export-oriented manufacturer and seller of compatible toner cartridges based in China, the U.S. and Europe, today announced its unaudited financi...
2024-09-14 04:45
7806
TOPBAND@2024 RE+, Exploring the Infinite Possibilities of Clean Energy
ANAHEIM, Calif., Sept. 13, 2024 /PRNewswire/ -- From September 10th to 12th, the RE+ exhibition, one of the most influential events in the energy sector, took place inAnaheim, USA. As an innovative leader in new energy, TOPBAND showcased itscutting-edge energy storage, charger, and integrated "P...
2024-09-13 21:00
2737
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation
SHANGHAI, Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today was informed by co-founders...
2024-09-13 19:30
6563
Cheetah Mobile Announces Second Quarter 2024 Unaudited Consolidated Financial Results
BEIJING, Sept. 13, 2024 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the second quarter endedJune 30, 2024. Management Commentary Mr. Sheng Fu, Cheetah Mobile's Ch...
2024-09-13 17:00
7036
Uxin Announces Entry into a Memorandum of Understanding for a Proposed Investment
BEIJING, Sept. 13, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company", together with its subsidiaries, the "Group") (Nasdaq: UXIN),China's leading used car retailer, today announced that it has entered into a memorandum of understanding ("MOU") with Pintu (Beijing) Information Technology ...
2024-09-13 17:00
5479
Mega Matrix Announced That the Romantic Short Drama "My Billionaire Ex Wants Me Back", Was First Released on September 10 at FlexTV
PALO ALTO, Calif., Sept. 13, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that it launched its revenge short drama "My Billionaire Ex Wants Me Back" onSeptember 10th at FlexTV. This emotionally charged drama immerses viewers in a gripping s...
2024-09-13 15:19
2745
RE+ 2024: Sungrow Unleashes Latest Solar, Storage, and Green Hydrogen Solutions, Bridging to a Sustainable Future
ANAHEIM, Calif., Sept. 13, 2024 /PRNewswire/ -- Sungrow, the global leading PV
inverter and energy storage system provider, unveiled its latest portfolio of
advanced solar, energy storage, and green hydrogen solutions at RE+ 2024 in
Anaheim, on September 9-12.
2024-09-13 15:05
3037
US FDA Grants RPD Designation to Senhwa Biosciences Silmitasertib for Pediatric Neuroblastoma
TAIPEI and SAN DIEGO, Sept. 13, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug Silmitasertib (CX-4945) was granted a rare pe...
2024-09-13 13:49
2283
iQIYI Sparks a New Wave in China's Comedy Scene with 'The King of Stand-up Comedy'
BEIJING, Sept. 13, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, has sparked a fresh surge of enthusiasm for stand-up comedy with the launch of its original show,The King of Stand-up Comedy. The show has quickly gained acclaim and generated widespread social buzz sinc...
2024-09-13 13:37
3685
/DISREGARD RELEASE: Tuya Smart/
We are advised by Tuya Smart that journalists and other readers should disregard the news release, "Tuya Smart Leads Industry Innovation with Groundbreaking Generative AI Integration", issued07-Jun-2024 by Tuya Smart over PR Newswire, as the release contained erroneous information. ...
2024-09-13 10:05
2894
Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults
CHENGDU, China, Sept.12, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") ofChina has recently approved the new drug application for Stapokibart (anti-IL-4Rα monoclonal antibody, trade name:Kangyueda (康悦达), for th...
2024-09-13 00:07
3158
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 295 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 284 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 282 media titles]
2026-10-15 12:59
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 271 media titles]
2026-10-21 15:00
Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
28284
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
17907